TOMM40 and TOMM22 of the Translocase Outer Mitochondrial Membrane Complex rescue statin-impaired mitochondrial dynamics, morphology, and mitophagy in skeletal myotubes

Author:

Yang Neil V.ORCID,Rogers Sean,Guerra Rachel,Pagliarini David J.ORCID,Theusch ElizabethORCID,Krauss Ronald M.

Abstract

ABSTRACTBackgroundStatins are the drugs most commonly used for lowering plasma low-density lipoprotein (LDL) cholesterol levels and reducing cardiovascular disease risk. Although generally well tolerated, statins can induce myopathy, a major cause of non-adherence to treatment. Impaired mitochondrial function has been implicated as a cause of statin-induced myopathy, but the underlying mechanism remains unclear. We have shown that simvastatin downregulates transcription ofTOMM40andTOMM22, genes that encode major subunits of the translocase of outer mitochondrial membrane (TOM) complex which is responsible for importing nuclear-encoded proteins and maintaining mitochondrial function. We therefore investigated the role ofTOMM40andTOMM22in mediating statin effects on mitochondrial function, dynamics, and mitophagy.MethodsCellular and biochemical assays and transmission electron microscopy were used to investigate effects of simvastatin andTOMM40andTOMM22expression on measures of mitochondrial function and dynamics in C2C12 and primary human skeletal cell myotubes.ResultsKnockdown ofTOMM40andTOMM22in skeletal cell myotubes impaired mitochondrial oxidative function, increased production of mitochondrial superoxide, reduced mitochondrial cholesterol and CoQ levels, disrupted mitochondrial dynamics and morphology, and increased mitophagy, with similar effects resulting from simvastatin treatment. Overexpression ofTOMM40andTOMM22in simvastatin-treated muscle cells rescued statin effects on mitochondrial dynamics, but not on mitochondrial function or cholesterol and CoQ levels. Moreover, overexpression of these genes resulted in an increase in number and density of cellular mitochondria.ConclusionThese results confirm that TOMM40 and TOMM22 are central in regulating mitochondrial homeostasis and demonstrate that downregulation of these genes by statin treatment mediates disruption of mitochondrial dynamics, morphology, and mitophagy, effects that may contribute to statin-induced myopathy.GRAPHICAL ABSTRACT

Publisher

Cold Spring Harbor Laboratory

Reference77 articles.

1. Cholesterol and atherosclerotic cardiovascular disease: A lifelong problem;J Am Heart Assoc,2019

2. Pharmacogenomics of statin response;Curr Opin Mol Ther,2008

3. Statin-associated muscle disease: Advantages in diagnosis and management;Neurotherapeutics,2018

4. The role of mitochondria in statin-induced myopathy

5. Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction;Oxf Med Case Reports,2018

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3